Brief: Mineralys Therapeutics Says It Announces Pricing Of Upsized $250.0 Million Underwritten Public Offering Of Common Stock
03/09/2025 02:34
Sept 2 (Reuters) - Mineralys Therapeutics Inc MLYS.O: MINERALYS THERAPEUTICS ANNOUNCES PRICING OF UPSIZED $250.0 MILLION UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK MINERALYS THERAPEUTICS INC - PRICES UPSIZED OFFERING OF 9,803,921 SHARES AT $25.50 EACH Source text: ID:nGNX9QmdHv Further company coverage: MLYS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mineralys Therapeutics
See all newsBrief: Mineralys Therapeutics Expands Its Board Of Directors With The Appointments Of Kristine Peterson And Lonnel Coats
Mineralys Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway